Karine Lheritier Selected Research

darifenacin

11/2007	Long-term darifenacin treatment for overactive bladder in patients aged 65 years and older: analysis of results from a 2-year, open-label extension study.
11/2006	Long-term treatment with darifenacin for overactive bladder: results of a 2-year, open-label extension study.
5/2006	Dose response with darifenacin, a novel once-daily M3 selective receptor antagonist for the treatment of overactive bladder: results of a fixed dose study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karine Lheritier Research Topics

Disease

3	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 07/2018 - 12/2012
3	Infections 01/2018 - 12/2012
3	Cryopyrin-Associated Periodic Syndromes 11/2017 - 01/2011
3	Overactive Urinary Bladder (Overactive Bladder) 11/2007 - 05/2006
2	Fever (Fevers) 01/2018 - 12/2012
2	Macrophage Activation Syndrome 01/2016 - 12/2012
1	Axial Spondyloarthritis 11/2021
1	Rheumatoid Arthritis 11/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2021
1	Psoriatic Arthritis 11/2021
1	Adult-Onset Still's Disease 07/2018
1	Familial Mediterranean Fever (Periodic Disease) 01/2018
1	Mevalonate Kinase Deficiency 01/2018
1	Body Weight (Weight, Body) 12/2012
1	Pain (Aches) 01/2011
1	Hypertension (High Blood Pressure) 08/2008
1	Osteoarthritis 08/2008
1	Nocturia 05/2006

Drug/Important Bio-Agent (IBA)

7	canakinumab FDA Link 07/2018 - 01/2011
3	darifenacin FDA Link 11/2007 - 05/2006
2	C-Reactive ProteinIBA 07/2018 - 12/2012
1	secukinumabIBA 11/2021
1	Colchicine FDA LinkGeneric 01/2018
1	Interleukin-1 (Interleukin 1)IBA 12/2012
1	GlucocorticoidsIBA 12/2012
1	lumiracoxib (prexige)IBA 08/2008
1	Antihypertensive Agents (Antihypertensives)IBA 08/2008
1	Ibuprofen (Motrin)FDA LinkGeneric 08/2008
1	Cholinergic Agents (Cholinergics)IBA 11/2007

Therapy/Procedure

1	Therapeutics 01/2011